UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

Annals of oncology, 2018-10, Vol.29, p.viii753-viii753

2018

Volltextzugriff (PDF)

Quality of Life After Permanent Implantation Prostate Brachytherapy Based on Prospective Questionnaire Data

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S441-S441

2014

Volltextzugriff (PDF)

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

The lancet oncology, 2019-08, Vol.20 (8), p.1148-1159

2019

Volltextzugriff (PDF)

PO-0967: Loose seeds vs. stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans

Radiotherapy and oncology, 2013-03, Vol.106, p.S374-S374

2013

Volltextzugriff (PDF)

IMPLEMENTATION OF IMAGE GUIDED RADIATION THERAPY PERFORMED WITH MEGAVOLTAGE CONE BEAM CT

Radiotherapy and oncology, 2009-08, Vol.92, p.S173-S173

2009

Volltextzugriff (PDF)

Dosimetric comparison between treatment plans of patients treated with low-dose–rate vs. high-dose–rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial

Brachytherapy, 2017-05, Vol.16 (3), p.608-615

2017

Volltextzugriff (PDF)

DOSIMETRIC COMPARISON BETWEEN PERMANENT VS. HIGHDOSE-RATE PROSTATE BRACHYTHERAPY

Radiotherapy and oncology, 2009-08, Vol.92, p.S137-S137

2009

Volltextzugriff (PDF)

230 oral MODERATE DOSE ESCALATION WITH SINGLE-FRACTION HIGH-DOSE-RATE BRACHYTHERAPY BOOST FOR CLINICALLY LOCALIZED INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER: FIVE-YEAR OUTCOME OF THE FIRST 100 CONSECUTIVELY TREATED PATIENTS

Radiotherapy and oncology, 2011, Vol.99, p.S88-S88

2011

Volltextzugriff (PDF)

ASSESSMENT OF OVERLAPPING OF ORGANS AT RISK AND PLANNING TARGET VOLUMES AT HIGH RISK PROSTATE CANCER IRRADIATION

Radiotherapy and oncology, 2009-08, Vol.92, p.S69-S69

2009

Volltextzugriff (PDF)

SP-0350: HDR brachytherapy in one fraction vs LDR brachytherapy in the treatment of localized prostate cancer. Early results

Radiotherapy and oncology, 2018-04, Vol.127, p.S182-S183

2018

Volltextzugriff (PDF)

OC-0210 Long-term results from the phase II/III Act.In.Sarc trial evaluating NBTXR3 in locally advanced STS

Radiotherapy and oncology, 2021-08, Vol.161, p.S142-S142

2021

Volltextzugriff (PDF)

Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer

Strahlentherapie und Onkologie, 2012-09, Vol.188 (9), p.816-822

2012

Volltextzugriff (PDF)

A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary

Pathology oncology research, 2017-10, Vol.23 (4), p.777-783

2017

Volltextzugriff (PDF)

NBTXR3 Activated By Radiotherapy Generates an Anti-Tumor Immune Response

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E651-E652

2019

Volltextzugriff (PDF)

Hafnium Oxide Nanoparticle Activated By Radiation Therapy Generates an Anti-Tumor Immune Response

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S204-S205

2018

Volltextzugriff (PDF)

High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1173-1181

2004

Volltextzugriff (PDF)

LBA66A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

OC-0271 First randomized study of Hafnium nanoparticles activated by radiotherapy in soft tissue sarcoma

Radiotherapy and oncology, 2019-04, Vol.133, p.S133-S134

2019

Volltextzugriff (PDF)

EP-1918: Dosimetric effects of different source arrangements in permanent prostate brachytherapy

Radiotherapy and oncology, 2014, Vol.111, p.S328-S329

2014

Volltextzugriff (PDF)

EP-1686: Hafnium oxide nanoparticles and radiotherapy for solid tumors: a promising new treatment strategy

Radiotherapy and oncology, 2018-04, Vol.127, p.S905-S906

2018

Volltextzugriff (PDF)

Surface and bulk properties of sputter deposited undoped and Sb-doped SnO@d2 thin films

Sensors and actuators. B, Chemical, 2009-06, Vol.139 (2), p.665-672

2009

Volltextzugriff (PDF)

EP-1557: Comparison of normal tissue dosimetry for 3D-CRT and IMRT techniques in prostate irradiation

Radiotherapy and oncology, 2014, Vol.111, p.S186-S186

2014

Volltextzugriff (PDF)

PO-1494: Dose integration method of intensitymodulated arc therapy and HDR brachytherapy of prostate cancer

Radiotherapy and oncology, 2020-11, Vol.152, p.S804-S804

2020

Volltextzugriff (PDF)

PO-2196 Dosimetric results of a randomised trial of HDR vs. LDR single dose BT of localised prostate cancer

Radiotherapy and oncology, 2023-05, Vol.182, p.S1977-S1979

2023

Volltextzugriff (PDF)

114 poster: Inverse vs. Geometrical and Graphical Optimization in High-Dose-Rate Prostate Brachytherapy Planning

Radiotherapy and oncology, 2009-05, Vol.91, p.S43-S43

2009

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(114)
Animals
(68)
Humans
(59)
Biological And Medical Sciences
(56)
Male
(46)
Female
(36)
Medical Sciences
(35)
Technology
(27)
Neurosciences & Neurology
(26)
Neurosciences
(24)
Middle Aged
(23)
Pharmacology. Drug Treatments
(22)
Computer Science
(21)
Fundamental And Applied Biological Sciences. Psychology
(21)
Artificial Intelligence
(19)
Exact Sciences And Technology
(19)
Computer Science, Theory & Methods
(18)
Neuropharmacology
(18)
Physical Sciences
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

Quality of Life After Permanent Implantation Prostate Brachytherapy Based on Prospective Questionnaire Data

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

PO-0967: Loose seeds vs. stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans

IMPLEMENTATION OF IMAGE GUIDED RADIATION THERAPY PERFORMED WITH MEGAVOLTAGE CONE BEAM CT

Dosimetric comparison between treatment plans of patients treated with low-dose–rate vs. high-dose–rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial

DOSIMETRIC COMPARISON BETWEEN PERMANENT VS. HIGHDOSE-RATE PROSTATE BRACHYTHERAPY

230 oral MODERATE DOSE ESCALATION WITH SINGLE-FRACTION HIGH-DOSE-RATE BRACHYTHERAPY BOOST FOR CLINICALLY LOCALIZED INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER: FIVE-YEAR OUTCOME OF THE FIRST 100 CONSECUTIVELY TREATED PATIENTS

ASSESSMENT OF OVERLAPPING OF ORGANS AT RISK AND PLANNING TARGET VOLUMES AT HIGH RISK PROSTATE CANCER IRRADIATION

SP-0350: HDR brachytherapy in one fraction vs LDR brachytherapy in the treatment of localized prostate cancer. Early results

OC-0210 Long-term results from the phase II/III Act.In.Sarc trial evaluating NBTXR3 in locally advanced STS

Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer

A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary

NBTXR3 Activated By Radiotherapy Generates an Anti-Tumor Immune Response

Hafnium Oxide Nanoparticle Activated By Radiation Therapy Generates an Anti-Tumor Immune Response

High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study

LBA66A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

OC-0271 First randomized study of Hafnium nanoparticles activated by radiotherapy in soft tissue sarcoma

EP-1918: Dosimetric effects of different source arrangements in permanent prostate brachytherapy

EP-1686: Hafnium oxide nanoparticles and radiotherapy for solid tumors: a promising new treatment strategy

Surface and bulk properties of sputter deposited undoped and Sb-doped SnO@d2 thin films

EP-1557: Comparison of normal tissue dosimetry for 3D-CRT and IMRT techniques in prostate irradiation

PO-1494: Dose integration method of intensitymodulated arc therapy and HDR brachytherapy of prostate cancer

PO-2196 Dosimetric results of a randomised trial of HDR vs. LDR single dose BT of localised prostate cancer

114 poster: Inverse vs. Geometrical and Graphical Optimization in High-Dose-Rate Prostate Brachytherapy Planning

Suchergebnisse filtern